lodelaben has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lines, LD; Maruyama, K; Rabinovitch, M; Silver, MM; Venkatacharya, H; Woo, M; Ye, CL | 1 |
| Hinz, JM; Molteni, A; Ts'ao, CH; Ward, WF | 1 |
2 other study(ies) available for lodelaben and Cardiac Hypertrophy
| Article | Year |
|---|---|
Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.
Topics: alpha 1-Antitrypsin; Animals; Cardiomegaly; Chlorobenzoates; Collagen; Elastic Tissue; Elastin; Fibronectins; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laminin; Male; Microscopy, Electron; Pancreatic Elastase; Pulmonary Artery; Rats; Rats, Inbred Strains | 1991 |
Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
Topics: Animals; Cardiomegaly; Chlorobenzoates; Epoprostenol; Hydroxyproline; Lung Diseases; Male; Monocrotaline; Organ Size; Pancreatic Elastase; Peptidyl-Dipeptidase A; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thromboxane A2; Tissue Plasminogen Activator | 1989 |